RxSight, Inc. RXST
NASDAQ
| 09/30/2026 | 06/30/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -27.13% | 9.22% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -27.13% | 9.22% | |||
| Cost of Revenue | -17.42% | 6.22% | |||
| Gross Profit | -30.08% | 10.16% | |||
| SG&A Expenses | -9.91% | -4.51% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -9.28% | -2.49% | |||
| Operating Income | -34.48% | 22.77% | |||
| Income Before Tax | -34.87% | 24.37% | |||
| Income Tax Expenses | -68.18% | 1,366.67% | |||
| Earnings from Continuing Operations | -34.12% | 23.84% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -34.12% | 23.84% | |||
| EBIT | -34.48% | 22.77% | |||
| EBITDA | -37.73% | 24.85% | |||
| EPS Basic | -33.40% | 24.16% | |||
| Normalized Basic EPS | -34.16% | 24.69% | |||
| EPS Diluted | -33.40% | 24.16% | |||
| Normalized Diluted EPS | -34.16% | 24.69% | |||
| Average Basic Shares Outstanding | 0.52% | 0.45% | |||
| Average Diluted Shares Outstanding | 0.52% | 0.45% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||